A carregar...
Testing SARS-CoV-2 vaccine efficacy through deliberate natural viral exposure
BACKGROUND: A vaccine trial with a conventional challenge design can be very fast once it starts, but it requires a long prior process, in part to grow and standardize challenge virus in the laboratory. This detracts somewhat from its overall promise for accelerated efficacy testing of severe acute...
Na minha lista:
| Publicado no: | Clin Microbiol Infect |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7787506/ https://ncbi.nlm.nih.gov/pubmed/33421580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmi.2020.12.032 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|